文献速递产科

胎儿性别与多囊卵巢综合征孕妇妊娠期糖尿病发生的关系

Fetal sex and the development of gestational diabetes mellitus in polycystic ovarian syndrome gravidae.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-02-08

本研究基于2011年9月至2021年6月一家学术机构2家医院超过3万人的数据库,比较患不孕症和多囊卵巢综合征的孕妇与无这些疾病的孕妇。在患不孕症和多囊卵巢综合征的孕妇中,女性胎儿与妊娠期糖尿病发生显著相关(未调整OR 2.13,95%CI 1.06-4.32,P=.03;调整后OR 2.10,95%CI 1.04-4.41,P=.04),而无不孕症和多囊卵巢综合征的孕妇中无显著关联(P=.99)。作者认为需进一步研究女性胎儿与母体多囊卵巢综合征背景下妊娠期糖尿病发生关联的分子机制。

要点

  • 患不孕症和多囊卵巢综合征的孕妇中,女性胎儿与妊娠期糖尿病发生显著相关。
  • 调整潜在混杂因素后,女性胎儿与妊娠期糖尿病的关联仍显著。
  • 无不孕症和多囊卵巢综合征的孕妇中,胎儿性别与妊娠期糖尿病无显著关联。

核心结论

  • 在患不孕症和多囊卵巢综合征的孕妇中,女性胎儿与妊娠期糖尿病发生相关,而在无这些疾病的对照孕妇中无此关联。
  • 作者认为需进一步研究女性胎儿与母体多囊卵巢综合征背景下妊娠期糖尿病发生关联的分子机制。

研究设计与样本

  • 基于一家学术机构2家医院数据库的队列研究,纳入2011年9月至2021年6月超过3万名受试者。
  • 识别分娩时诊断为不孕症和多囊卵巢综合征的孕妇,并与无这些疾病的孕妇比较。
  • 收集母亲年龄、体重指数、胎儿性别、种族、民族、有无高血压疾病、有无妊娠期糖尿病等协变量数据,计算未调整和调整比值比。

主要发现

  • 患不孕症和多囊卵巢综合征的孕妇中,女性胎儿与妊娠期糖尿病发生显著相关(女性 vs 男性,未调整OR 2.13,95%CI 1.06-4.32,P=.03)。
  • 调整单因素分析中识别的潜在混杂因素后,女性胎儿与妊娠期糖尿病发生仍显著相关(女性 vs 男性,调整OR 2.10,95%CI 1.04-4.41,P=.04)。
  • 无不孕症和多囊卵巢综合征的孕妇中,胎儿性别与妊娠期糖尿病发生无显著关联(P=.99)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polycystic ovarian syndrome is characterized by elevated androgens and is a well-known risk factor for the occurrence of gestational diabetes mellitus. Androgens (particularly dehydroepiandrosterone-sulfate) are crucial for the development and characteristics of the male reproductive tract during fetal life, and fetal dehydroepiandrosterone-sulfate enters the placenta where it is metabolized and functions as an estrogen substrate. Given this unique sex-specific relationship with androgens and the association of serum dehydroepiandrosterone-sulfate concentration with insulin resistance, we hypothesized that metabolic comorbidities in pregnancy might differ by fetal sex in gravidae with polycystic ovarian syndrome, notably in those with infertility. OBJECTIVE: This study aimed to evaluate the data in a large population-based database to explore if fetal sex was significantly associated with gestational diabetes mellitus in gravidae with infertility and polycystic ovarian syndrome after controlling for confounders. STUDY DESIGN: This study was designed to evaluate the risk for the occurrence and rates of gestational diabetes mellitus among gravidae with infertility and a history of polycystic ovarian syndrome. We used a 2-hospital, single academic institution database comprising more than 30,000 subjects enrolled from September 2011 to June 2021 to identify all gravidae with diagnoses of infertility and polycystic ovarian syndrome at the time of delivery and to compare them with gravidae who lacked these comorbidities. Data on covariates, including but not limited to maternal age, body mass index, fetal sex, race, ethnicity, presence or absence of hypertensive disease, and presence or absence of gestational diabetes were identified. Unadjusted and adjusted odds rations were calculated. RESULTS: We found a statistically significant association between fetal female sex and the development of gestational diabetes mellitus in gravidae with polycystic ovarian syndrome (odds ratio for female vs male, 2.13; 95% confidence interval, 1.06-4.32; P=.03). After adjusting for potential confounders identified in our univariate analyses, there continued to be a statistically significant association between female fetuses and the development of gestational diabetes mellitus (adjusted odds ratio for female vs male, 2.10; 95% confidence interval, 1.04-4.41; P=.04). In contrast, there was no significant association between fetal sex and the development of gestational diabetes mellitus in our similar analysis of gravidae without infertility and polycystic ovarian syndrome (P=.99). CONCLUSION: Although the origin of gestational diabetes mellitus is multifactorial, we found that female fetal sex is associated with gestational diabetes mellitus in gravidae with infertility and polycystic ovarian syndrome but not in their comparative controls. Further research on the molecular mechanisms driving the association between female fetuses and the development of gestational diabetes mellitus in the context of maternal polycystic ovarian syndrome is warranted.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Sassin AM, Sangi-Haghpeykar H, Aagaard KM, et al. Fetal sex and the development of gestational diabetes mellitus in polycystic ovarian syndrome gravidae. Am J Obstet Gynecol MFM. 2023. PMID: 36758681. doi:10.1016/j.ajogmf.2023.100897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。